Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

July 31, 2000

Study Completion Date

October 31, 2005

Conditions
Multiple Myeloma and Plasma Cell Neoplasm
Interventions
DRUG

dexamethasone

DRUG

isotretinoin

Trial Locations (18)

15905

Conemaugh Memorial Hospital, Johnstown

16602

Bon Secours-Holy Family Health System, Altoona

19026

Delaware County Memorial Hospital, Drexel Hill

19047

Saint Mary Regional Center, Langhorne

19111

Fox Chase Cancer Center, Philadelphia

19390

Southern Chester County Medical Center, West Grove

19464

Pottstown Memorial Regional Cancer Center, Pottstown

08822

Hunterdon Regional Cancer Center, Flemington

08701

Kimball Medical Center, Lakewood

08332

South Jersey Regional Cancer Center, Millville

08060

Fox Chase Cancer Center at Virtua Memorial Hospital Burlington County, Mount Holly

07701

Riverview Medical Center - Booker Cancer Center, Red Bank

08755

Community Medical Center, Toms River

08629

St. Francis Medical Center, Trenton

17105-8700

Pinnacle Health Hospitals, Harrisburg

19446-1200

North Penn Hospital, Lansdale

19301-1792

Paoli Memorial Hospital, Paoli

19612-6052

Reading Hospital and Medical Center, Reading

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT00021359 - Isotretinoin Plus Dexamethasone in Treating Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter